Navigation Links
SCAI's Annual Fall Fellows Course Prepares New Interventional Cardiologists to Work in the Field

LAS VEGAS, Dec. 8 /PRNewswire/ -- The end of fall marks an exciting time for interventional cardiologists about to enter the field and begin their professional careers. Fellows from around the world will gather this week to attend the Society for Cardiovascular Angiography and Interventions (SCAI) Third Annual Interventional Cardiology Fall Fellows Course in Las Vegas, December 8-12.

Given the aging population and the increasing number of people with cardiovascular disease, proper training of interventional cardiologists is essential to ensure the greatest chance of survival in cardiovascular patients. In the event of a heart attack or stroke, interventional cardiologists are the physicians called upon to perform life-saving treatments, such as angioplasty and stenting, a procedure where plaque is removed and a small mesh tube is inserted into the artery to prop it open.

Offered to fellows in their final year of training, the course provides a unique opportunity for fellows to interact with internationally recognized faculty, further their education with guidance from premiere practicing physicians, and learn the latest cutting-edge technology in the field. Fellows attend five days of expense-free hands-on workshops, live-case medical simulations, and clinical case presentations. New to this year's course are programs focused on pediatric and congenital cardiology, which SCAI plans to make a permanent addition to the Fall Fellows Course curriculum.

"The Fall Fellows Course is a unique opportunity for adult and pediatric interventionalists-in-training to receive final preparation before entering the real world as full-fledged specialists," said SCAI President Ziyad M. Hijazi, MD, MPH, FSCAI, FACC, FAAP. "We hope by the time they leave this course, they feel prepared to provide optimal care to patients, manage interventional complications, and face clinical situations. Throughout the years we have hosted this course, we have seen 90 percent of the interventional cardiology fellows from the United States, plus others from around the world."

This year, 250 fellows from 18 countries will test their skills and take part in unique hands-on simulations as they prepare to practice in the real world. The fellows also gain a well-rounded and in-depth knowledge of indications, techniques and expected outcomes for interventional cardiac, carotid, structural, congenital and endovascular procedures.

"Today physicians learn and perfect their craft by participating in hands-on activities and simulations," said SCAI Immediate Past President Bonnie Weiner, MD, MSEC, MBA, FSCAI. "This course provides fellows the opportunity to ensure they can perform their every-day job to the best of their ability. Participation in state-of-the-art practices and working with seasoned experts in the field is a totally unique and invaluable experience." Dr. Weiner, Michael J. Cowley, MD, FSCAI, and Christopher U. Cates, MD, FSCAI, are the Program Directors of SCAI's Third Annual Interventional Cardiology Fall Fellows Course.

Throughout the course, sessions cover interventional pharmacology; coronary, carotid, renal, and peripheral intervention; bifurcation lesions; structural heart disease; congenital heart disease; and practice management topics important in establishing an interventional cardiology practice.

The course is provided at no cost to participants, thanks to generous support from Abbott Vascular, Access Closure, ACIST Medical, AGA Medical, Biosense Webster, Inc., Boston Scientific, Cook Medical, Cordis Cardiac & Vascular Institute, Daiichi Sankyo - Eli Lilly, Datascope, Genentech, Immersion, InfraReDx, Medical Simulation Corp., Medtronic, Inc., Mentice, Inc., PICS Foundation, Radi Medical Systems, sanofi aventis, Schering-Plough, Simbionix, St. Jude Medical, Terumo Interventional Systems, The Medicines Company, and Volcano Corporation.

About SCAI

Headquartered in Washington, D.C., the Society for Cardiovascular Angiography and Interventions is a 4,000-member professional organization representing invasive and interventional cardiologists in more than 60 nations. SCAI's mission is to promote excellence in invasive and interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care. SCAI's annual meeting has become the leading venue for education, discussion, and debate about the latest developments in this dynamic medical specialty. SCAI's new patient and physician education program, Seconds Count, offers comprehensive information about cardiovascular disease. For more information about SCAI and Seconds Count, visit or

SOURCE Society for Cardiovascular Angiography and Interventions
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
2. Late-breaking data to be presented at the American Society of Hematology Annual Meeting
3. Hologic to Present at the J.P. Morgan 27th Annual Healthcare Conference
4. REGiMMUNE to present GvHD data at the 50th ASH Annual Meeting
5. Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto
6. How to Ensure Your Companys Survival: Leaders to Discuss at the 11th Annual Customer Experience Conference in Las Vegas
7. MaxCyte to Present Targeted Cancer Immunotherapy Product at 50th Annual Meeting of the American Society of Hematology
8. Nu Skin Enterprises Offers 2009 Guidance During Annual Investor Day
9. 50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases
10. HLTH Corporation and WebMD to Webcast Annual Meetings of Stockholders
11. Stryker Increases Annual Dividend by Over 20%
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... ... The print component of “Supporting Our Caregivers” is distributed ... Minneapolis, South Florida, with a circulation of approximately 250,000 copies and an estimated ... media strategy and across a network of top news sites and partner media ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
Breaking Medicine Technology: